SciTransfer
Organization

CBK SCI CON LIMITED

Scientific computing consultancy specializing in high-performance multiscale simulation for exascale applications and computational biomedicine.

Technology SMEdigitalUKSMENo active H2020 projects
H2020 projects
4
As coordinator
0
Total EC funding
€1.5M
Unique partners
28
What they do

Their core work

CBK Sci Con is a London-based scientific computing consultancy specializing in high-performance and multiscale computing for complex simulations. They provide expertise in designing computing patterns, performance measurement, and verification methods for exascale applications. Their work bridges computational infrastructure with domain-specific applications, particularly in computational biomedicine and precision medicine. They help research consortia build and optimize simulation workflows that run efficiently on supercomputing infrastructure.

Core expertise

What they specialise in

High-performance multiscale computingprimary
4 projects

Central theme across all four projects — ComPat, CompBioMed, VECMA, and CompBioMed2 — covering computing patterns, performance prediction, and exascale methods.

Computational biomedicine simulationprimary
2 projects

Core participant in both CompBioMed (2016-2019) and CompBioMed2 (2019-2024), the flagship Centre of Excellence in Computational Biomedicine.

Verified exascale computingsecondary
1 project

Contributed to VECMA (2018-2021), focused on verification and validation methods for exascale multiscale applications.

Performance measurement and predictionsecondary
1 project

ComPat project explicitly targeted performance measurement and prediction for multiscale computing patterns.

Evolution & trajectory

How they've shifted over time

Early focus
Multiscale computing patterns and performance
Recent focus
Exascale computational biomedicine

In their early H2020 period (2015-2018), CBK Sci Con focused on foundational multiscale computing patterns, performance measurement, and building experimental execution environments — essentially the computational infrastructure layer. From 2018 onward, their work shifted toward applying these methods at exascale and in domain-specific contexts, particularly personalised medicine and biomedicine simulation. The continuation from CompBioMed to CompBioMed2 (with significantly increased funding) shows a deepening commitment to computational biomedicine as their primary application domain.

Moving from general HPC methodology toward domain-applied exascale simulation, with computational biomedicine as their anchor application area.

Collaboration profile

How they like to work

Role: specialist_contributorReach: European11 countries collaborated

CBK Sci Con operates exclusively as a consortium participant, never as coordinator, which is consistent with a specialist consultancy that brings targeted HPC expertise to larger research initiatives. With 28 unique partners across 11 countries from just 4 projects, they work in large, international consortia — typical of EU Centres of Excellence and flagship computing projects. Their repeat involvement in CompBioMed and CompBioMed2 suggests they are valued enough to be re-invited, indicating reliable delivery and strong working relationships.

Well-connected across 11 countries with 28 unique consortium partners, primarily through large-scale HPC and computational biomedicine networks. Their repeat presence in CompBioMed projects places them within Europe's top computational biomedicine community.

Why partner with them

What sets them apart

As a private SME consultancy rather than a university or research institute, CBK Sci Con occupies an unusual niche in the HPC research ecosystem — they bring commercial agility and focused computing expertise to academic-heavy consortia. Their combination of deep multiscale computing methodology with applied biomedicine experience makes them a rare bridge between HPC infrastructure developers and domain scientists. For consortium builders, they offer specialist computing architecture knowledge without the overhead of engaging a large institution.

Notable projects

Highlights from their portfolio

  • CompBioMed2
    Their largest project by far (EUR 763K), a continuation of the Centre of Excellence in Computational Biomedicine running through 2024, signaling sustained trust and growing responsibility.
  • VECMA
    Focused on verification and validation for exascale computing — a critical methodological capability that underpins confidence in large-scale simulation results.
  • ComPat
    Their earliest H2020 project, establishing foundational work on multiscale computing patterns that informed their later, larger engagements.
Cross-sector capabilities
Health and precision medicineComputational life sciencesResearch infrastructure and e-infrastructureAdvanced manufacturing simulation
Analysis note: Profile based on 4 projects with consistent thematic focus, providing reasonable confidence. No website available for verification of commercial activities beyond H2020. The company's exact service offerings and team size are inferred from project roles and SME status. Funding growth from EUR 128K to EUR 763K across projects suggests increasing scope of contribution.